Pharma dominates in climate scorecard; FDA hears need for opioid REMS;

> AstraZeneca and Johnson & Johnson led the pharmaceutical industry in besting 13 other industries on the nonprofit Climate Counts' climate change scorecard, which measures corporate efforts to reduce emissions. Report l Release

> Steve Hayes, director of Novus Medical Detox Center, and Larry Golbom, host of The Prescription Addiction Radio Show testified before the FDA in late May about the need for Risk Evaluation Mitigation Strategies (REMS) for opioids, especially OxyContin. Release

> GlaxoSmithKline has opened a $600 million ($414 million US) vaccine manufacturing plant as part of a 10-year strategy. Article

> Contract manufacturer CoreRx will purchase an 80,000-square-foot facility in Florida for the formulation, analysis and production of clinical trial quantities of pharmaceuticals. Article

> Formulation development and clinical trial materials maker Metrics has consolidated its quality-related operations and promoted Tom Wilson to VP for quality operations. Announcement

Suggested Articles

CureVac and Tesla are teaming up to produce the German vaccine maker's molecular RNA printers, Tesla CEO Elon Musk tweeted Thursday.

The FDA knocked a California compounding pharmacy facility for a suite of sanitary concerns, including the presence of ants in the plant.

Merck Animal Health will plow $100 million into its DeSoto, Kansas, plant to scale up production of animal vaccines.